Imbio PHA (4.0.0) vs Ligence Heart
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA if your primary need is rapid, AI-powered analysis of CT pulmonary angiogram (CTPA) scans to assess right ventricular dilation. This tool is ideal for radiologists and pulmonologists needing to quickly quantify cardiac structures and ratios (RV/LV, PA/Ao) to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension, leveraging existing CT data.
View Imbio PHA (4.0.0) →Choose Ligence Heart if…
Choose Ligence Heart if your focus is on automating the comprehensive analysis and reporting of 2D transthoracic echocardiography studies. This platform is best suited for cardiologists and sonographers seeking to enhance efficiency and accuracy in quantifying various echo measurements (e.g., area, volume, strain, Doppler) and recognizing a broad range of cardiac diseases like heart failure and valvular issues directly from echocardiography data.
View Ligence Heart →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | Ligence Heart |
|---|---|---|
| Pricing | Unknown | Contact-for-pricing |
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Cloud-based; on-premise; hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio PHA (4.0.0)Imbio PHA emphasizes a fully automated, rapid assessment that integrates seamlessly into existing DICOM workflows, requiring no new user interfaces for clinicians, which minimizes disruption to clinical practice. It provides annotated DICOM images and summary reports in PDF format, fitting into established radiology workflows. While Ligence Heart is web-based and intuitive, Imbio's approach of not requiring new user interfaces offers a slightly lower barrier to adoption for radiologists.
Clinical Value
Ligence HeartLigence Heart offers a broader range of AI-driven features for echocardiography, including automated strain, spectral and tissue Doppler measurements, and disease recognition for multiple conditions like heart failure, cardiomyopathy, and valvular heart diseases. Its recent FDA clearance for automated Left Ventricular Strain analysis further demonstrates its expanding capabilities. While Imbio PHA provides critical measurements for pulmonary embolism and hypertension from CTPA scans, Ligence Heart's comprehensive echocardiography analysis covers a wider spectrum of cardiac pathologies.
Pricing & Value
TieBoth Imbio PHA and Ligence Heart require direct contact for pricing information, indicating a lack of public transparency regarding their cost structures. Without specific pricing details or publicly available return on investment (ROI) data, it is not possible to definitively compare their value propositions.
Enterprise Readiness
Imbio PHA (4.0.0)Imbio PHA demonstrates strong enterprise readiness with explicit third-party HIPAA certification by Compliancy Group and flexible deployment options including cloud, on-premise, or via a wide range of partners such as Nuance, Aidoc, and Siemens Syngo.via. This extensive partner ecosystem and explicit third-party compliance verification give it a slight edge in proven integration and security for large healthcare systems. Ligence Heart also offers robust integration and compliance but does not detail third-party certification or as broad a partner network.
Innovation
Ligence HeartLigence Heart appears to offer a broader and more advanced set of AI-driven features for echocardiography, including automated strain, spectral and tissue Doppler measurements, and disease recognition for multiple conditions. The recent FDA clearance for fully automated Left Ventricular Strain analysis highlights its ongoing and expanding innovation in advanced cardiac analysis. While Imbio PHA is innovative in its specific application to CTPA, Ligence Heart's continuous development in diverse echocardiographic measurements suggests a wider scope of innovation.
Support & Docs
TieBoth companies demonstrate a commitment to user support and product improvement. Imbio PHA provides a user manual and emphasizes a user-experience driven roadmap, working with clients and key opinion leaders. Ligence Heart highlights its dedicated team's focus on optimization, quicker software updates, immediate developer feedback, and a user-centric approach informed by user feedback. Without more specific details on support channels, service level agreements (SLAs), or the breadth of documentation, it is difficult to distinguish a clear winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | Ligence Heart |
|---|---|---|
| Name | Imbio PHA (4.0.0) | Ligence Heart |
| Company | Imbio | Ligence |
| Description | Imbio PHA (4.0.0) is an FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. | Ligence Heart is an AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers. |
| Primary Imaging Modality | CT pulmonary angiogram (CTPA) scans | 2D transthoracic echocardiography |
| Key Features (Cardiac Measurements) | Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios | Automated calculation of measurements and report generation; Area, Distance, Doppler, and Volume quantification; Automated strain, Spectral and Tissue Doppler measurements |
| Integration | Integrates with native DICOM tools and workflows | Integration with existing systems (PACS, EHR, RIS) |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Ligence Heart.